BfArM - Bundesinstitut für Arzneimittel und Medizinprodukte

Navigation und Service

SSRIs, venlafaxine and mirtazapine and the risk of Persistent Pulmonary Hypertension in Neonates (PPHN) - Final SPC and PL wording agreed by the PhVWP in March 2010

20.12.2010

SSRIs, venlafaxine and mirtazapine and the risk of Persistent Pulmonary Hypertension in Neonates (PPHN)

SSRIs, venlafaxine and mirtazapine and the risk of Persistent Pulmonary Hypertension in Neonates (PPHN) - Final SPC and PL wording agreed by the PhVWP in March 2010 PDF, 32KB, barrierefrei ⁄ barrierearm